Market Research Logo

Global Generic Drugs Market 2018-2022

Global Generic Drugs Market 2018-2022

About Generic Drugs

A generic drug is a medication created to be the equivalent of an existing approved brand-name drug in terms of dosage form, safety, strength, route of administration, quality, and performance characteristics.

Technavio’s analysts forecast the Global Generic Drugs Market to grow at a CAGR of 10.22% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the generic drugs market. To calculate the market size, the report considers the revenue generated from the sales of generic drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, generic drugs market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Fresenius Kabi
  • Mylan
  • Novartis
  • Pfizer
  • Sun Pharmaceutical Industries
  • Teva Pharmaceutical Industries
Market driver
  • Rising drug patient expirations
  • For a full, detailed list, view our report
Market challenge
  • Rising credibility issues
  • For a full, detailed list, view our report
Market trend
  • Rising M&A
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceutical market: Market size
      • Table Global pharmaceutical market: Segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global generic drugs market - Market size and forecast 2017-2022 ($ bn)
      • Table Global generic drugs market - Year over year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by application
    • Anti-infectives
    • CNS
    • Others
  • Market segmentation by category
    • Segmentation by category
      • Table Global generic drugs market by category - Market share 2017-2022 (%)
    • Comparison by category
      • Table Comparison by category
    • Small molecule generics - Market size and forecast 2017-2022
      • Table Global generic drugs market by small molecule generics - Market size and forecast 2017-2022 ($ bn)
      • Table Global generic drugs market by small molecule generics - Year over year growth 2018- 2022 (%)
    • Biosimilars - Market size and forecast 2017-2022
      • Table Global generic drugs market by biosimilars - Market size and forecast 2017-2022 ($ bn)
      • Table Global generic drugs market by biosimilars - Year over year growth 2018-2022 (%)
    • Market opportunity by category
      • Table Market opportunity by category
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global generic drugs market by region - Market share 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Generic drugs market in Americas - Market size and forecast 2017-2022 ($ bn)
      • Table Generic drugs market in Americas - Year over year growth 2018-2022 (%)
      • Table Top three countries in Americas
    • APAC - Market size and forecast 2017-2022
      • Table Generic drugs market in APAC - Market size and forecast 2017-2022 ($ bn)
      • Table Generic drugs market in APAC - Year over year growth 2018-2022 (%)
      • Table Top three countries in APAC
    • EMEA - Market size and forecast 2017-2022
      • Table Generic drugs market in EMEA - Market size and forecast 2017-2022 ($ bn)
      • Table Generic drugs market in EMEA - Year over year growth 2018-2022 (%)
      • Table Top three countries in EMEA
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Exhibit: Drug patent expirations in 2018
    • Market challenges
  • Market trends
    • Advent of RPA
    • Rising M&A
    • Hospital-owned generics
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Fresenius Kabi
      • Table Fresenius Kabi overview
      • Table Fresenius Kabi - Business segments
      • Table Fresenius Kabi - Organizational developments
      • Table Fresenius Kabi - Geographic focus
      • Table Fresenius Kabi - Segment focus
      • Table Fresenius Kabi - Key offerings
    • Mylan
      • Table Mylan overview
      • Table Mylan - Business segments
      • Table Mylan - Organizational developments
      • Table Mylan - Segment focus
      • Table Mylan - Key offerings
    • Novartis
      • Table Novartis overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
    • Pfizer
      • Table Pfizer overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
    • Sun Pharmaceutical Industries
      • Table Sun Pharmaceutical Industries overview
      • Table Sun Pharmaceutical Industries - Business segments
      • Table Sun Pharmaceutical Industries - Organizational developments
      • Table Sun Pharmaceutical Industries - Geographic focus
      • Table Sun Pharmaceutical Industries - Segment focus
      • Table Sun Pharmaceutical Industries - Key offerings
    • Teva Pharmaceutical Industries
      • Table Teva Pharmaceutical Industries overview
      • Table Teva Pharmaceutical Industries - Business segments
      • Table Teva Pharmaceutical Industries - Organizational developments
      • Table Teva Pharmaceutical Industries - Geographic focus
      • Table Teva Pharmaceutical Industries - Segment focus
      • Table Teva Pharmaceutical Industries - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report